Earnings Feed
Start Free
Home/Filings/4/0001185185-17-001921
4//SEC Filing

TOMAS MIKE 4

Accession 0001185185-17-001921

CIK 0001388319other
View on SEC.govCompany Profile

Filed

Aug 31, 8:00 PM ET

Accepted

Sep 1, 4:01 PM ET

Size

8.2 KB

Accession

0001185185-17-001921

Insider Transaction Report

Form 4
Period: 2017-08-07
U.S. Stem Cell, Inc.USRM
TOMAS MIKE
DirectorCEO & President
Transactions
  • Award

    Stock Option (right to buy)

    2017-08-07+15,000,000→ 36,841,284 total
    Exercise: $0.03Exp: 2027-08-07→ Common Stock (15,000,000 underlying)
  • Award

    Stock Option (right to buy)

    2017-08-07+1,500,000→ 38,341,284 total
    Exercise: $0.03From: 2017-08-07Exp: 2017-08-07→ Common Stock (1,500,000 underlying)
Holdings

  • Common Stock

    9,793
Footnotes (1)
  • [F1]3,750,000 vest on 08/07/2018, 3,750,000 vest on 08/07/2019, 3,750,000 vest on 08/07/2020, and 3,750,000 vest on 08/07/2021.

Documents

1 file

Issuer

U.S. Stem Cell, Inc.

CIK 0001388319

→
Entity typeother

Related Parties

1
  • filerCIK 0001388662

Filing Metadata

Form type
4
Filed
Aug 31, 8:00 PM ET
Accepted
Sep 1, 4:01 PM ET
Size
8.2 KB
View on SEC.gov